Market Recap Check: Celestica, Inc (CLS)’s Positive Finish at 114.03, Up/Down 1.22

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

The price of Celestica, Inc (NYSE: CLS) closed at $114.03 in the last session, up 1.22% from day before closing price of $112.66. In other words, the price has increased by $1.22 from its previous closing price. On the day, 4.79 million shares were traded.

Ratios:

We take a closer look at CLS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.63. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.66.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on February 21, 2025, initiated with a Overweight rating and assigned the stock a target price of $166.

CIBC Upgraded its Neutral to Sector Outperform on January 31, 2025, while the target price for the stock was maintained at $150.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 31 ’25 when Laurette Koellner bought 100,000 shares for $82.69 per share.

Laurette T Koellner bought 151,717 shares of CLS for $13,945,827 on Mar 19 ’25. On Feb 07 ’25, another insider, Cooper Todd C, who serves as the President of the company, sold 65,000 shares for $129.78 each. As a result, the insider received 8,435,794 and left with 110,426 shares of the company.

Valuation Measures:

As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.86, and their Forward P/E ratio for the next fiscal year is 18.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 8.47.

Stock Price History:

Over the past 52 weeks, CLS has reached a high of $144.27, while it has fallen to a 52-week low of $40.25. The 50-Day Moving Average of the stock is 26.72%, while the 200-Day Moving Average is calculated to be 37.62%.

Shares Statistics:

A total of 115.60M shares are outstanding, with a floating share count of 114.39M. Insiders hold about 0.52% of the company’s shares, while institutions hold 76.72% stake in the company.

Earnings Estimates

Celestica, Inc (CLS) is currently under the scrutiny of 10.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $1.28, with high estimates of $1.31 and low estimates of $1.26.

Analysts are recommending an EPS of between $5.15 and $5.0 for the fiscal current year, implying an average EPS of $5.04. EPS for the following year is $6.1, with 11.0 analysts recommending between $6.65 and $5.54.

Revenue Estimates

According to 9 analysts, the current quarter’s revenue is expected to be $2.65B. It ranges from a high estimate of $2.66B to a low estimate of $2.64B. As of the current estimate, Celestica, Inc’s year-ago sales were $2.39BFor the next quarter, 9 analysts are estimating revenue of $2.76B. There is a high estimate of $2.79B for the next quarter, whereas the lowest estimate is $2.72B.

A total of 11 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $11.1B, while the lowest revenue estimate was $10.85B, resulting in an average revenue estimate of $10.93B. In the same quarter a year ago, actual revenue was $9.65BBased on 11 analysts’ estimates, the company’s revenue will be $12.77B in the next fiscal year. The high estimate is $13.37B and the low estimate is $12.27B.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.